Content about Gabapentin

September 26, 2012

A drug maker is suing the Food and Drug Administration to force the agency to give a special designation to one of its drugs.

July 30, 2012

The Food and Drug Administration has approved Watson Pharmaceuticals’ Next Choice One Dose (levonorgestrel) tablets in the 1.5-mg strength.

July 24, 2012

A district court ruled in favor of Pfizer and Northwestern University in a patent infringement case relating to Lyrica (pregabalin).

July 5, 2012

The Food and Drug Administration has approved Lupin Pharmaceuticals' generic version of a drug used to treat pain and seizure disorders.

June 7, 2012

The Food and Drug Administration has approved a drug made by GlaxoSmithKline and XenoPort for treating pain associated with shingles.

May 2, 2012

The Food and Drug Administration has approved a generic drug for epilepsy made by Acella Pharmaceuticals, the company said Wednesday.

April 12, 2012

Generic drug maker Impax Labs is challenging the patent protection on a drug used to treat postherpetic neuralgia, the company said Thursday.

October 10, 2011

Depomed has launched a new drug for treating shingles, the drug maker said Monday.

August 11, 2011

Drug makers GlaxoSmithKline and XenoPort are seeking expanded approval for their restless legs syndrome treatment.

April 25, 2011

SUPPLIER NEWS — Hi-Tech Pharmacal announced the tentative approval by the Food and Drug Administration of levofloxacin oral solution in the 25-mg/mL strength, a generic antibiotic. Levofloxacin oral solution is a generic version of Johnson & Johnson’s Levaquin, which had sales of $6 million in 2010, according to IMS Health. Hi-Tech expected to receive final approval in June, when Johnson & Johnson’s patent expires.


April 7, 2011

The Food and Drug Administration has approved a drug made by GlaxoSmithKline and Xenoport for treating restless legs syndrome, the agency said Thursday.

February 28, 2011

The Food and Drug Administration has approved a treatment for shingles made by a subsidiary of generic drug maker Mylan.

February 22, 2011

Generic drug maker Hi-Tech Pharmacal has received Food and Drug Administration approval for its version of a drug used to treat neurological disorders, the company said Tuesday.

July 19, 2010

Drug maker Pfizer is suspending some clinical studies of a biotech drug for treating pain...

June 23, 2010

Reports of worsening conditions among patients has led drug maker Pfizer to suspend a clinical...

June 3, 2010

The Food and Drug Administration has approved Mylan’s version of a drug for complications related...

March 21, 2010

A once-a-day formulation of a Pfizer drug potentially could capture half of the market for...

February 17, 2010

The Food and Drug Administration has declined to approve a drug used to treat restless...

January 26, 2010

A topical treatment for post-herpetic neuralgia, more commonly known as shingles, has received an orphan...

© 2014 Drug Store News. All Rights Reserved.